ArticleStem cell research & therapy2021

Low-dose IL-34 has no effect on osteoclastogenesis but promotes osteogenesis of hBMSCs partly via activation of the PI3K/AKT and ERK signaling pathways.

Jianxiang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.